Search - tctmd.com

Displaying 781 - 800 of 1039

Sort: Relevancy | Date

Presentation TCT 2013

Do I Really Need Bioresorbable Scaffolds in the United States?

Presenter: Gregg Stone

October 28, 2013

News Conference News TCT 2013

Memories of TCT 1988 and Beyond: Marvin L. Woodall

October 28, 2013

News Industry News

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

October 28, 2013

News Conference News TCT 2013

ABSORB III and IV Trials Aim to Prove Superiority of BVS

October 28, 2013

Presentation TCT 2013

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB IV Clinical Trial

Presenter: Gregg Stone

October 27, 2013

Presentation

HORIZONS-AMI: Reduction in Cardiac Mortality with Bivalirudin in Patients With and Without Major Bleeding

Presenter: Gregg W. Stone

October 16, 2013

News Daily News

共识报告详述血小板反应性与缺血、出血的关联

L.A. McKeown

October 15, 2013

News Daily News

Un Estudio de Consenso Detalla el Nexo entre la Reactividad Plaquetaria y la Isquemia y las Hemorrgias

L.A. McKeown

October 15, 2013

News Daily News

Consensus Paper Details Link Between Platelet Reactivity and Ischemia, Bleeding

L.A. McKeown

October 15, 2013

News Daily News

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

Caitlin E. Cox

October 11, 2013

News Daily News

INFUSE-AMI: El Descenso del Tamaño del Infarto a los 30 Días podría Traducirse en Beneficios al cabo de 1 Años

Caitlin E. Cox

October 11, 2013

Presentation

Intralesional Abciximab and Thrombus Aspiration in Patients with Large Anterior MI: 1-Year Results of INFUSE-AMI

Presenter: Gregg W. Stone

October 04, 2013

News Daily News

El Recuento Basal de Glóbulos Blancos Predice el Tamaño del Infarto en los STEMI Anteriores

Yael L. Maxwell

September 27, 2013

News Daily News

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

Yael L. Maxwell

September 27, 2013

Presentation

Critical Appraisal of the ESC 2013 Late Breaking Trials: TASTE, PRAMI and ACCOAST

Presenter: Gregg W. Stone

September 24, 2013

News Daily News

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

September 20, 2013

News Daily News

Meta-análisis de SPIRIT confirma superioridad total de Xience sobre Taxus

September 20, 2013

News Daily News

Meta-analysis: DES More Effective Than BMS for STEMI with No Safety Trade-off

L.A. McKeown

August 19, 2013

News Daily News

Meta Análisis: Los SLF son Más Eficaces que los SMD para los cuadros de STEMI Sin Compensación de la Seguridad

L.A. McKeown

August 19, 2013

News Opinion Conversations in Cardiology

Conversations in Cardiology: Door-to-Balloon Time

August 19, 2013

Advertisement

Do I Really Need Bioresorbable Scaffolds in the United States?

Memories of TCT 1988 and Beyond: Marvin L. Woodall

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

ABSORB III and IV Trials Aim to Prove Superiority of BVS

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB IV Clinical Trial

HORIZONS-AMI: Reduction in Cardiac Mortality with Bivalirudin in Patients With and Without Major Bleeding

共识报告详述血小板反应性与缺血、出血的关联

Un Estudio de Consenso Detalla el Nexo entre la Reactividad Plaquetaria y la Isquemia y las Hemorrgias

Consensus Paper Details Link Between Platelet Reactivity and Ischemia, Bleeding

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

INFUSE-AMI: El Descenso del Tamaño del Infarto a los 30 Días podría Traducirse en Beneficios al cabo de 1 Años

Intralesional Abciximab and Thrombus Aspiration in Patients with Large Anterior MI: 1-Year Results of INFUSE-AMI

El Recuento Basal de Glóbulos Blancos Predice el Tamaño del Infarto en los STEMI Anteriores

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

Critical Appraisal of the ESC 2013 Late Breaking Trials: TASTE, PRAMI and ACCOAST

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

Meta-análisis de SPIRIT confirma superioridad total de Xience sobre Taxus

Meta-analysis: DES More Effective Than BMS for STEMI with No Safety Trade-off

Meta Análisis: Los SLF son Más Eficaces que los SMD para los cuadros de STEMI Sin Compensación de la Seguridad

Conversations in Cardiology: Door-to-Balloon Time

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content